acitretin has been researched along with Psoriasis Arthropathica in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Amici, JM; Bergqvist, C; Beylot-Barry, M; Corgibet, F; Ly, S; Sbidian, E; Seï, JF; Seneschal, J | 1 |
| Asili, P; Daneshpajooh, M; Mirahmad, M; Nasimi, M; Sedaghatzadeh, M; Tootoonchi, N | 1 |
| Silverberg, JI; Singh, P | 1 |
| Frambach, Y; Gerdes, S; Jacobi, A; Mössner, R; Philipp, S; Schill, T; Steinz, K; Weyergraf, A; Wilsmann-Theis, D | 1 |
| Dutz, JP; Khosravi-Hafshejani, T; Zhou, Y | 1 |
| Alsina, M; Belinchón, I; Carrascosa, JM; Carretero, G; de la Cueva, P; Ferrándiz, C; Fonseca, E; García-Bustínduy, M; García-Patos, V; Herrera, E; Lafuente-Urrez, RF; López-Estebaranz, JL; Marrón, SE; Moreno, JC; Notario, J; Puig, L; Ribera, M; Rivera, R; Rodriguez-Cerdeira, C; Romero, A; Ruiz-Villaverde, R; Sánchez-Regaña, M; Taberner, R; Vidal, D | 1 |
| Biterman, H; Cohen, AD; Feldhamer, I; Freud, T; Greenberg-Dotan, S; Harman-Boehm, I; Moser, H; Polishchuk, I; Shalom, G; Zisman, D | 1 |
| Ghoreschi, K; Volc, S | 1 |
| Boulinguez, S | 1 |
| Cerri, A; Colombo, L; Crespi, E; Gualandri, L; Mapelli, ET; Marconi, M; Menni, S | 1 |
| Fournié, B; Godfrin, B; Latour, FB; Loustau, O; Railhac, JJ; Vincent, V; Zabraniecki, L | 1 |
| Girard, C; Guilhou, JJ | 1 |
| Daoud, L; Dhaoui, MR; Doss, N; Jaber, K; Youssef, S | 1 |
| Elston, CM; O'Toole, EA; Webber, NK | 1 |
| Alegre de Miguel, V; Martínez Casimiro, L; Sánchez Carazo, JL | 1 |
| Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS | 1 |
3 review(s) available for acitretin and Psoriasis Arthropathica
| Article | Year |
|---|---|
Pathophysiological basis of systemic treatments in psoriasis.
Topics: Acitretin; Arthritis, Psoriatic; Biosimilar Pharmaceuticals; Dermatologic Agents; Humans; Psoriasis | 2016 |
[Psoriasis].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Psoriatic; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; HIV Infections; Humans; Infant; Infant, Newborn; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Skin; Time Factors; Vitamins | 2006 |
[Long-term control of psoriasis is necessary].
Topics: Acitretin; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Recurrence | 2008 |
13 other study(ies) available for acitretin and Psoriasis Arthropathica
| Article | Year |
|---|---|
CITY-PSO: Prescribing behaviour of French private-practice dermatologists in psoriasis management: An observational, multicentre, cross-sectional study.
Topics: Acitretin; Adult; Aged; Arthritis, Psoriatic; Cross-Sectional Studies; Dermatologists; Humans; Middle Aged; Psoriasis; Severity of Illness Index | 2022 |
Demographic aspects, clinical characteristics, and therapeutic approaches in geriatric psoriasis: A study from a tertiary center.
Topics: Acitretin; Aged; Arthritis, Psoriatic; Cross-Sectional Studies; Demography; Female; Humans; Male; Middle Aged; Psoriasis | 2022 |
Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis.
Topics: Acitretin; Adalimumab; Administration, Oral; Adult; Arthritis, Psoriatic; Biological Products; Dermatologic Agents; Drug Utilization; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Phototherapy; Psoriasis; Ustekinumab | 2020 |
Palmoplantar pustulosis - a cross-sectional analysis in Germany.
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Age of Onset; Arthritis, Psoriatic; Body Mass Index; Comorbidity; Cross-Sectional Studies; Dermatologic Agents; Female; Germany; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Smoking; Ultraviolet Therapy; Young Adult | 2017 |
Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
Topics: Acitretin; Acrodermatitis; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Humans; Interleukin-17; Keratolytic Agents; Male; Middle Aged; Treatment Outcome; Withholding Treatment | 2019 |
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Topics: Acitretin; Adult; Age Factors; Arthritis, Psoriatic; Biological Factors; Child; Clinical Trials as Topic; Combined Modality Therapy; Cost-Benefit Analysis; Drug Substitution; Evidence-Based Medicine; Female; Humans; Immunosuppressive Agents; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Photochemotherapy; Pregnancy; Pregnancy Complications; Psoriasis; Severity of Illness Index; Sex Factors; Spain; Treatment Failure; Treatment Outcome | 2013 |
Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
Topics: Acitretin; Administration, Oral; Adult; Age Factors; Aged; Arthritis, Psoriatic; Databases, Factual; Dermatologic Agents; Drug Prescriptions; Female; Folic Acid; Humans; Israel; Kaplan-Meier Estimate; Keratolytic Agents; Male; Medication Adherence; Metabolic Syndrome; Methotrexate; Middle Aged; Psoriasis | 2015 |
[News on psoriasis from the 2010 Dermatology Days in Paris].
Topics: Acitretin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Immunoglobulin G; Methotrexate; Practice Guidelines as Topic; Psoriasis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome; Ustekinumab | 2011 |
Superimposed linear psoriasis: low effectiveness of biologic therapy.
Topics: Acitretin; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Biological Therapy; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Loss of Heterozygosity; Male; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor | 2011 |
Acitretin-induced enthesitis in a patient with psoriatic arthritis.
Topics: Acitretin; Ankle Joint; Arthritis, Psoriatic; Arthrography; Follow-Up Studies; Humans; Keratolytic Agents; Ligaments, Articular; Male; Middle Aged; Ossification, Heterotopic; Tomography, X-Ray Computed | 2005 |
[Management of severe psoriasis: about 50 cases].
Topics: Acitretin; Adolescent; Adult; Aged; Arthritis, Psoriatic; Child; Dermatitis, Exfoliative; Female; Follow-Up Studies; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Retinoids; Retrospective Studies; Treatment Outcome | 2007 |
Generalized pustular psoriasis and cryptogenic organizing pneumonia.
Topics: Acitretin; Adult; Arthritis, Psoriatic; Cryptogenic Organizing Pneumonia; Cyclosporine; Dermatologic Agents; Etanercept; Fatal Outcome; Female; Humans; Immunoglobulin G; Protein C Inhibitor; Psoriasis; Receptors, Tumor Necrosis Factor | 2008 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha | 2008 |